Rallybio has dosed the first subject in a trial of a potential treament for foetal and neonatal alloimmune thrombocytopaenia (FNAIT).

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

"Velocity and VCT to address double enrolment challenge in clinical trials" was originally created and published by Clinical ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

"We are pleased to report that the first subject in the subacute cohort of our Phase 1b/2a clinical trial in traumatic SCI has been enrolled and dosed. We believe that the protocol amendment will ...

Quantum BioPharma Ltd (NASDAQ:QNTM) shares are rising Tuesday after the company announced positive clinical trial results for ...

The Subject Expert Committee (SEC), which advises the Central drug regulator, has recommended grant of permission to Glenmark Pharmaceuticals to import and market cancer drug tislelizumab injection in ...

In a survey, less than half of cancer patients and their family members said they were willing to participate in a clinical trial, and about a third of respondents said they had a positive perception ...

Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and operational framework ...

Trials in China usually recruit patients faster than in the west because of the country’s large pool of people who have not yet taken drugs for their condition and who are keen to participate in ...

Supreme Court's Justice Jamal Mandokhail on Wednesday raised question regarding the scope of the Army Act's jurisdiction, ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...